rs966106333

Variant summary

Our verdict is Uncertain significance. The variant received 4 ACMG points: 4P and 0B. PM1PM2

The NM_176787.5(PIGN):​c.2590G>A​(p.Val864Ile) variant causes a missense change. The variant allele was found at a frequency of 0.0000143 in 1,603,034 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000026 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000013 ( 0 hom. )

Consequence

PIGN
NM_176787.5 missense

Scores

3
7
9

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 4.84

Publications

0 publications found
Variant links:
Genes affected
PIGN (HGNC:8967): (phosphatidylinositol glycan anchor biosynthesis class N) This gene encodes a protein that is involved in glycosylphosphatidylinositol (GPI)-anchor biosynthesis. The GPI-anchor is a glycolipid found on many blood cells and serves to anchor proteins to the cell surface. This protein is expressed in the endoplasmic reticulum and transfers phosphoethanolamine (EtNP) to the first mannose of the GPI anchor. Two alternatively spliced variants, which encode an identical isoform, have been reported. [provided by RefSeq, Jul 2008]
PIGN Gene-Disease associations (from GenCC):
  • multiple congenital anomalies-hypotonia-seizures syndrome 1
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P, Orphanet, ClinGen, PanelApp Australia
  • Fryns syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 4 ACMG points.

PM1
In a hotspot region, there are 2 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 1 benign, 9 uncertain in NM_176787.5
PM2
Very rare variant in population databases, with high coverage;

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PIGNNM_176787.5 linkc.2590G>A p.Val864Ile missense_variant Exon 29 of 31 ENST00000640252.2 NP_789744.1 O95427A0A024R2C3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PIGNENST00000640252.2 linkc.2590G>A p.Val864Ile missense_variant Exon 29 of 31 1 NM_176787.5 ENSP00000492233.1 O95427
PIGNENST00000400334.7 linkc.2590G>A p.Val864Ile missense_variant Exon 28 of 30 1 ENSP00000383188.2 O95427
PIGNENST00000638424.1 linkn.*558G>A non_coding_transcript_exon_variant Exon 27 of 29 5 ENSP00000491963.1 A0A1W2PQZ1
PIGNENST00000638424.1 linkn.*558G>A 3_prime_UTR_variant Exon 27 of 29 5 ENSP00000491963.1 A0A1W2PQZ1

Frequencies

GnomAD3 genomes
AF:
0.0000264
AC:
4
AN:
151248
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000589
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.00000815
AC:
2
AN:
245470
AF XY:
0.00000751
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000180
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000131
AC:
19
AN:
1451786
Hom.:
0
Cov.:
27
AF XY:
0.0000180
AC XY:
13
AN XY:
722486
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33202
American (AMR)
AF:
0.00
AC:
0
AN:
44394
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25958
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39410
South Asian (SAS)
AF:
0.00
AC:
0
AN:
85276
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53262
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5704
European-Non Finnish (NFE)
AF:
0.0000172
AC:
19
AN:
1104598
Other (OTH)
AF:
0.00
AC:
0
AN:
59982
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.457
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000264
AC:
4
AN:
151248
Hom.:
0
Cov.:
32
AF XY:
0.0000407
AC XY:
3
AN XY:
73750
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41178
American (AMR)
AF:
0.00
AC:
0
AN:
15180
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3464
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5136
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4790
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10338
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
312
European-Non Finnish (NFE)
AF:
0.0000589
AC:
4
AN:
67868
Other (OTH)
AF:
0.00
AC:
0
AN:
2072
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000227

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Multiple congenital anomalies-hypotonia-seizures syndrome 1 Uncertain:1
Aug 24, 2021
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces valine with isoleucine at codon 864 of the PIGN protein (p.Val864Ile). The valine residue is moderately conserved and there is a small physicochemical difference between valine and isoleucine. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals affected with PIGN-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.13
BayesDel_addAF
Uncertain
0.080
D
BayesDel_noAF
Benign
-0.11
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Benign
0.032
T;.;T;T;T;.;.;.;.;.;T;.;.;T;.;T;.;.
Eigen
Pathogenic
0.74
Eigen_PC
Pathogenic
0.72
FATHMM_MKL
Uncertain
0.96
D
LIST_S2
Uncertain
0.95
.;.;.;.;.;.;D;.;D;D;.;D;D;.;D;D;D;D
M_CAP
Benign
0.033
D
MetaRNN
Uncertain
0.51
D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D
MetaSVM
Benign
-0.39
T
MutationAssessor
Uncertain
2.8
M;.;M;M;M;.;.;.;.;.;M;.;.;M;.;M;.;.
PhyloP100
4.8
PrimateAI
Uncertain
0.55
T
PROVEAN
Benign
-0.87
.;.;.;N;.;.;.;.;.;.;N;.;.;.;.;.;.;.
REVEL
Benign
0.23
Sift
Pathogenic
0.0
.;.;.;D;.;.;.;.;.;.;D;.;.;.;.;.;.;.
Sift4G
Benign
0.087
.;.;.;T;.;.;.;.;.;.;T;.;.;.;.;.;.;.
Polyphen
1.0
D;.;D;D;D;.;.;.;.;.;D;.;.;D;.;D;.;.
Vest4
0.46, 0.46
MutPred
0.44
Loss of catalytic residue at V864 (P = 0.0094);.;Loss of catalytic residue at V864 (P = 0.0094);Loss of catalytic residue at V864 (P = 0.0094);Loss of catalytic residue at V864 (P = 0.0094);.;.;Loss of catalytic residue at V864 (P = 0.0094);.;.;Loss of catalytic residue at V864 (P = 0.0094);Loss of catalytic residue at V864 (P = 0.0094);.;Loss of catalytic residue at V864 (P = 0.0094);.;Loss of catalytic residue at V864 (P = 0.0094);Loss of catalytic residue at V864 (P = 0.0094);Loss of catalytic residue at V864 (P = 0.0094);
MVP
0.69
MPC
0.072
ClinPred
0.95
D
GERP RS
5.7
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.46
gMVP
0.37
Mutation Taster
=76/24
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.13
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs966106333; hg19: chr18-59742041; API